The findings presented here also support the role of NRP1 as a malignancy biomarker and highlight the potential of developing new strategies for the design and use of mechanical tumor microenvironment regulators as a potential strategy to modulate the expression of proteins involved in cancer progression. The gene discussed is NRP1; the disease is cancer.